SCHEMBL46737

SCHEMBL46737

CN1c2ccc(Br)cc2Oc2ccc(Br)cc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 4/20 0.52
▸ PIM1 P11309 3/20 0.36
▸ BLM P54132 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ NPR1 P16066 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ CASP2 P42575 1/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ CA12 O43570 1/20 0.32
▸ CA2 P00918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31314363 0.92 AHR (0.54) AHRBLMLMNAMAPTHTT
SCHEMBL19417416 0.92 AHR (0.54) AHRPIM1BLMLMNAMAPT
SCHEMBL19417350 0.87 AHR (0.55) AHRBLMLMNAMAPTHTT
SCHEMBL19417312 0.87 AHR (0.55) AHRLMNAMAPTKDM4EALDH1A1
SCHEMBL19417415 0.83 AHR (0.46) AHRMAPTTSHRMEN1KMT2A
SCHEMBL19417334 0.82 AHR (0.44) AHRPIM1BLMLMNAMAPT
SCHEMBL19417332 0.82 AHR (0.44) AHRBLMLMNAMAPTHTT
SCHEMBL31314477 0.78 AHR (0.44) AHRKDM4EALDH1A1NFKB1HTR2A
SCHEMBL13231753 0.76 KDM4E (0.35) MAPTHTTPKMTSHRKDM4E
SCHEMBL31314293 0.75 CYP2A6 (0.44) AHRMAPTCYP1A2TP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012003642-A1 FUSED TRICYCLIC COMPOUNDS AND USE THEREOF FOR TREATING VIRAL DISEASES MERCK SHARP & DOHME CORP. (US) 2012-01-12 — — WO disclosed
Send feedback